Sang-A Frontec Co Ltd

As of March 31, 2026, Sang-A Frontec Co Ltd carries a market capitalization of 337.02B, placing it among publicly traded companies globally. Its enterprise value stands at 413.92B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sang-A Frontec Co Ltd's next confirmed earnings release is scheduled for November 12, 2026.

As of March 31, 2026, Sang-A Frontec Co Ltd has 15.64M shares outstanding.

As of March 31, 2026, Sang-A Frontec Co Ltd trades at a trailing price-to-earnings ratio of 46.71. The price-to-sales ratio is 1.65, and the price-to-book ratio stands at 1.65.

As of March 31, 2026, Sang-A Frontec Co Ltd trades at an EV/EBITDA multiple of 17.85 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 60.91 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 413.92B versus a market cap of 337.02B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Sang-A Frontec Co Ltd maintains a current ratio of 0.97, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 68.24, indicating elevated leverage, while an interest coverage ratio of 3.72 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Sang-A Frontec Co Ltd posted a return on equity (ROE) of 3.58, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 1.86, measuring how efficiently the asset base is converted into earnings. The company generates approximately 412.52M in revenue per employee across its workforce of 494.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.75 indicates how many times Sang-A Frontec Co Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Sang-A Frontec Co Ltd recorded an income tax benefit of -1.06B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 6.13B, leaving 7.20B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Sang-A Frontec Co Ltd's stock has declined approximately 22.26% over the past 52 weeks. The 50-day moving average sits at 15,054.40, while the 200-day moving average is 18,452.50.

Over the twelve months ended March 31, 2026, Sang-A Frontec Co Ltd generated 203.78B in revenue and converted that into 7.20B in net income, yielding earnings per share of 459.67. EBITDA reached 23.19B, while operating income came in at 6.80B.

As of March 31, 2026, Sang-A Frontec Co Ltd holds 62.22B in cash and equivalents against 139.13B in total debt, resulting in a net debt position of 109.91B. Total book value stands at 203.88B, with working capital of -4.53B providing operational flexibility.

Sang-A Frontec Co Ltd produced 22.58B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -19.99B in capital expenditures, free cash flow totaled 2.58B - equivalent to 165.64 per share.

Over the twelve months ended March 31, 2026, Sang-A Frontec Co Ltd posted a gross margin of 17.38, reflecting its pricing power and cost economics. The operating margin of 3.33 and net profit margin of 3.53 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Sang-A Frontec Co Ltd paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 0.77, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.84, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Sang-A Frontec Co Ltd shareholders.

As of March 31, 2026, Sang-A Frontec Co Ltd has an Altman Z-Score of 2.06, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.